Using ultrasound to assess lung lymph nodes in sarcoidosis patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the use of endobronchial ultrasound strain elastography (EBUS-SE) to evaluate lymph nodes in patients with sarcoidosis. The study aims to determine if EBUS-SE can identify fibrotic lymph nodes, which may be associated with inadequate sampling during biopsies. By analyzing the elasticity of lymph nodes, the researchers hope to improve diagnostic accuracy and patient outcomes. The study will include patients with a clinical or radiological suspicion of sarcoidosis across various stages.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 years or older.
* ASA physical status I-III.
* Clinical/radiological (computed tomography) suspicion of sarcoidosis (Stages I to III)

Exclusion Criteria:

* Inability or unwillingness to consent.
* Severe bleeding disorders
* Contraindication for temporary interruption of the use of anticoagulant or antiplatelet therapy different from aspirin.
* Recent and/or uncontrolled cardiac disease, uncontrolled pulmonary hypertension.
* Compromised upper airway (eg, concomitant head and neck cancer or central airway stenosis for any reason).
* Pregnancy

Where it's running

• Fondazione Policlinico Universitario A. Gemelli IRCCS
  Roma, Italy Recruiting

Study contacts

• Study coordinator: Rocco Trisolini, MD
• Email: rocco.trisolini@policlinicogemelli.it
• Phone: +390630154204

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using hydroxychloroquine to reduce steroid use in patients with extrapulmonary sarcoidosis

  This study is testing if hydroxychloroquine can help people with extrapulmonary sarcoidosis manage their symptoms while using fewer steroids.

  Recruiting at 6 sites Phase 4 Hospices Civils de Lyon · Avignon and 20 other locations · NCT05841758

• Using semaglutide to treat advanced lung disease

  This study is testing if a diabetes and weight loss medication called semaglutide can be safely used by adults with advanced lung diseases to see if it helps them manage their weight better.

  Recruiting Phase 1/2 University of Pennsylvania · Philadelphia, Pennsylvania · NCT05746039

• Developing prediction models for sarcoidosis progression

  This study is trying to find out which signs and blood tests can help predict how sarcoidosis will progress in adults with the condition.

  Recruiting at 2 sites University of California, San Francisco · Baltimore, Maryland and 1 other locations · NCT05567133

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.